MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC EV/EBITDA 2011-2026 | OXFD
EV/EBITDA Jährlich Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | -73.4 | -11 | -8.91 | -11.9 | -7.71 | -7.65 | -0.465 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.465 | -73.4 | -17.3 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Biomerica
BMRA
|
-6.24 | $ 2.13 | - | $ 4.89 M |  USA |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
-187 | $ 75.5 | -0.31 % | $ 5.1 B | USA |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
30.7 | $ 455.28 | -0.36 % | $ 13.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
 |
Mettler-Toledo International
MTD
|
827 | $ 1 229.6 | -0.87 % | $ 25.3 B |  Schweiz |
 |
Charles River Laboratories International
CRL
|
22 | $ 156.54 | -0.92 % | $ 7.76 B | USA |
 |
IQVIA Holdings
IQV
|
24.1 | $ 165.42 | -0.95 % | $ 28.4 B | USA |
 |
Myriad Genetics
MYGN
|
-17.2 | $ 4.6 | -1.29 % | $ 426 M | USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-7.71 | $ 1.25 | -14.38 % | $ 6.81 M | USA |
 |
National Research Corporation
NRC
|
21 | $ 17.47 | -0.26 % | $ 391 M | USA |
 |
Interpace Biosciences
IDXG
|
-6.02 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
IDEXX Laboratories
IDXX
|
45.3 | $ 569.86 | -1.5 % | $ 45.8 B | USA |
 |
Illumina
ILMN
|
70.5 | $ 122.99 | -0.65 % | $ 19.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
38 | $ 100.22 | -0.13 % | $ 8.27 B |  Irlanda |
 |
Guardant Health
GH
|
-28.8 | $ 84.35 | -0.65 % | $ 10.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B |  Niderland |
 |
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.38 | -1.08 % | $ 414 M | USA |
 |
Celcuity
CELC
|
-2.38 | $ 103.02 | -3.49 % | $ 4.06 B | USA |
 |
Precipio
PRPO
|
-1.8 | $ 26.93 | - | $ 35 M | USA |
 |
Personalis
PSNL
|
-7.07 | $ 7.71 | 1.37 % | $ 457 M | USA |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 263.52 | -0.36 % | $ 21.9 B | USA |
 |
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | Israel |
 |
RadNet
RDNT
|
17.6 | $ 60.39 | -2.19 % | $ 4.54 B | USA |
 |
ENDRA Life Sciences
NDRA
|
0.831 | $ 3.41 | -2.16 % | $ 1.83 M | USA |
 |
NeoGenomics
NEO
|
-33.5 | $ 7.91 | -2.35 % | $ 1.01 B | USA |
 |
Agilent Technologies
A
|
27.4 | $ 111.72 | -0.27 % | $ 34 B | USA |
 |
Natera
NTRA
|
-19.5 | $ 194.13 | -2.98 % | $ 19.1 B | USA |
 |
CareDx, Inc
CDNA
|
-100 | $ 17.24 | -1.82 % | $ 919 M | USA |
 |
OPKO Health
OPK
|
25.9 | $ 1.14 | -0.88 % | $ 791 M | USA |
 |
Senseonics Holdings
SENS
|
-13.8 | $ 6.58 | -0.68 % | $ 275 M | USA |
 |
Castle Biosciences
CSTL
|
-21.2 | $ 25.84 | 0.35 % | $ 718 M | USA |
 |
Sotera Health Company
SHC
|
24.8 | $ 13.77 | -0.79 % | $ 3.91 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 194.57 | -0.54 % | $ 21.6 B | USA |
 |
DarioHealth Corp.
DRIO
|
-1.05 | $ 7.37 | -1.73 % | $ 29.4 M | Israel |